Purpose
Intermittent preventive treatment with sulfadoxine-pyrimethamine is widely used for the prevention of malaria in pregnant women in Africa. Known resistance cases of sulfadoxine-pyrimethamine during pregnancy need to be follow up to support IPTp implementation in Burkina Faso. However, data on the development and spread of resistance to this molecule are lacking. This study aimed to investigating the genetic diversity of
P. falciparum
and the mutation prevalence in the
dhfr
and
dhps
genes infected from postpartum infected placentas.
Patients and Methods
This was a prospective and cross-sectional study conducted between April 2019 and March 2020 in four health districts of Ouagadougou capital city. From the placentas collected after delivery,
P. falciparum
detection and
mps1
and
msp2
polymorphism analysis were performed by nested PCR. The resistance profile was checked after analyzing the mutation point on
dhfr
and
dhps
genes.
Results
PCR-positive samples were estimated at 96% for
msp1
and 98% for
msp2
. The polymorphism analysis showed that the RO33 and 3D7 allelic families were the most widespread with 62.5% and 91.83%, respectively. Multiple infections by
msp1
and
msp2
were frequent with 12.50% and 92.92%, respectively. The prevalence of individual
dhfr
mutation point, 51I, 108A, and 59R, was 1.96, 15.68, and 7.84, respectively, and the
dhps
mutation point, 437G, was 3.92. There is no detected mutation at the point 164L and 540E. The triple (51I+108A+59R) in
dhfr
and quadruple (51I+108A+59R+ 437G) mutation were not found.
Conclusion
The results showed that
Plasmodium falciparum
has a high genetic diversity of
msp1
and
msp2
. This suggests that
dhfr
and
dhps
mutant genotypes are potential early warning factors in the increase in the sulfadoxine-pyrimethamine resistance.